M. G. F. Harmani Kalim, “Empagliflozin Attenuates Cardiac Fibrosis via Suppression of TLR2/NF-κB Signaling in a Rat Model of Metabolic Syndrome”, Trends Sci, vol. 23, no. 9, p. 13423, Apr. 2026.